CD27

CD27 Overview

English NameCD27 antigenApproved Drugs0
Drugs in Clinical Trials4Target SynonymCD27 antigen,Tumor necrosis factor receptor superfamily member 7,CD27L receptor,CD27,CD27 Molecule,T-Cell Activation Antigen CD27,TNFRSF7,T14,T Cell Activation Antigen S152,S152. LPFS2,S152,Tp55,Tumor Necrosis Factor Receptor Superfamily, Member 7
Highest Development StagePhase 2 Clinical
English NameCD27 antigen
Target SynonymCD27 antigen,Tumor necrosis factor receptor superfamily member 7,CD27L receptor,CD27,CD27 Molecule,T-Cell Activation Antigen CD27,TNFRSF7,T14,T Cell Activation Antigen S152,S152. LPFS2,S152,Tp55,Tumor Necrosis Factor Receptor Superfamily, Member 7
Approved Drugs0
Drugs in Clinical Trials4
Highest Development StagePhase 2 Clinical

CD27 Product List

  • Product Category

    Protein (6)

  • Product Status

    Launched (6)

  • Species

    Human (4)Cynomolgus / Rhesus macaque (1)Mouse (1)

  • Tag

    Fc Tag (1)Fc Tag & Avi Tag (1)Mouse IgG Fc Tag (3)His Tag (1)

  • Conjugate

    Unconjugated (5)Biotin-labeled (1)

CD27 Background

CD Antigen CD27 is also known as Tumor necrosis factor receptor superfamily member 7 (TNFRSF7), which belongs to TNF-receptor superfamily. CD27 / TNFRSF7 is found in most T-lymphocytes. CD27 / TNFRSF7 is required for generation and long-term maintenance of T cell immunity. It binds to ligand CD70, and plays a key role in regulating B-cell activation and immunoglobulin synthesis. This receptor transduces signals that lead to the activation of NF-κB and MAPK8/JNK. CD27 has been shown to interact with SIVA1, TRAF2 and TRAF3.

CD27 Synonyms

CD27,TNFRSF7,S152,T14,Tp55

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
BoserolimabMK-5890Phase 2 ClinicalAduro Biotech Europe BvSolid tumours; Triple Negative Breast Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
VarlilumabCDX-1127Phase 2 ClinicalCelldex TherapeuticsLung Neoplasms; Lymphoma, Primary Effusion; Cholangiocarcinoma; Prostatic Neoplasms; Bile Duct Neoplasms; Urologic Neoplasms; Astrocytoma; Burkitt Lymphoma; Lymphoma, Non-Hodgkin; Gallbladder Neoplasms; Lymphoma, T-Cell; Plasmablastic Lymphoma; Urogenital Neoplasms; Glioma; Leukemia, Lymphocytic, Chronic, B-Cell; Melanoma; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Leukemia, T-Cell; Large intestine neoplasm; Central Nervous System Lymphoma; Skin Neoplasms; Solid tumours; Kidney Neoplasms; Head and Neck Neoplasms; Lymphoma, B-Cell, Marginal Zone; Ovarian Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Lymphomatoid Granulomatosis; Lymphoma, Large B-Cell, Diffuse; Lymphoma, B-Cell; Glioblastoma; Neoplasms; Kidney Diseases; Triple Negative Breast Neoplasms; Hormone-Resistant Prostate Neoplasms; Urinary Bladder Neoplasms; Urologic Diseases; Oligodendroglioma; Lymphoma, Mantle-Cell
Details
LOR-S03CDX-527Phase 1 ClinicalCelldex TherapeuticsOvarian Neoplasms; Liver Neoplasms; Solid tumours; Head and Neck Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Breast Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
Anti-CD27 monoclonal antibody (Aduro Biotech)BION-1402Phase 1 ClinicalAduro Biotech IncNeoplasms
Details

Product Reviews

  • W***I2025-11-07
    0People Like
    This protein is used for binding activity experiments. According to pre-confirmation data, accuracy, precision, durability, linearity, and range all meet the validation acceptance criteria and can be used as a translational research.
  • Overview
  • Product List
  • Product Reviews
  • Clinical Drug Information